Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGonzález Albarrán, Olga
dc.contributor.authorMorales, Cristóbal
dc.contributor.authorPérez-Maraver, Manuel
dc.contributor.authorAparicio-Sánchez, José Juan
dc.contributor.authorSimó Canonge, Rafael
dc.date.accessioned2022-09-12T08:30:05Z
dc.date.available2022-09-12T08:30:05Z
dc.date.issued2022-07
dc.identifier.citationGonzález-Albarrán O, Morales C, Pérez-Maraver M, Aparicio-Sánchez JJ, Simó R. Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D. Diabetes Ther. 2022 Jul;13(Suppl 1):35–49.
dc.identifier.issn1869-6961
dc.identifier.urihttps://hdl.handle.net/11351/8140
dc.descriptionAlbuminuria; Enfermedad renal diabética; Diabetes tipo 2
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesDiabetes Therapy;13(Supl 1)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectDiabetis no-insulinodependent - Complicacions
dc.subjectFetge - Càncer - Tractament
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.mesh/complications
dc.subject.meshKidney Diseases
dc.subject.mesh/therapy
dc.titleReview of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s13300-022-01276-2
dc.subject.decsdiabetes mellitus tipo II
dc.subject.decs/complicaciones
dc.subject.decsenfermedades renales
dc.subject.decs/terapia
dc.relation.publishversionhttps://doi.org/10.1007/s13300-022-01276-2
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[González-Albarrán O] Endocrinology and Nutrition Department, Gregorio Marañón Hospital, Madrid, Spain. [Morales C] Endocrinology and Nutrition Department, Virgen Macarena Hospital, Seville, Spain. Hospital Vithas Sevilla, Seville, Spain. [Pérez-Maraver M] Endocrinology and Nutrition Unit, Bellvitge University Hospital-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. [Aparicio-Sánchez JJ] Medical Affairs Department, AstraZeneca Farmacéutica Spain, Madrid, Spain. [Simó R] Diabetes and Metabolism Research Group, VHIR, Endocrinology Department, Vall d’Hebron University Hospital, Autonomous University Barcelona, 08035, Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
dc.identifier.pmid35704167
dc.identifier.wos000811438400003
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple